This is a type of dendritic cell vaccine in which autologous peripheral blood mononuclear cells collected from the patient are exposed to a fusion protein consisting of prostate acid phosphatase (PAP), an antigen of prostate cancer cells, and granulocyte‐macrophage colony‐stimulating factor (GM‐CSF). The gene discussed is ACP3; the disease is prostate carcinoma.